17 September 2021>: Original Paper
Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions
Mehmet Tanrısev 1ABCDEF* , Tülay Ayna Kılıçaslan 2CD , Hülya Çolak 1BFG , Sibel Ersan 1BD , Banu Yılmaz 1BFG , Alper Alp 3B , Cem Tuğmen 4BC , Bahar Engin Sevgili 5EDOI: 10.12659/AOT.932434
Ann Transplant 2021; 26:e932434
Table 2 Biochemical analysis features of the study groups.
Variables | mTOR group (n=37) mean±SD | CNI group (n=52) mean±SD | p |
---|---|---|---|
Post-transplant creatinine (mg/dl) | 1.20±0.3 | 1.30±0.3 | 0.060 |
Actual creatinine (mg/dl) | 1.32±0.5 | 1.43±0.5 | 0.330 |
Post-transplant eGFR (ml/min per/1.73 m) | 67.4±16 | 63±12.8 | 0.230 |
Actual eGFR (ml/min per/1.73 m) | 59.7±20 | 57±17 | 0.520 |
Post-transplant spot urine protein/creatinine | 0.1±0.2 | 0.14±0.3 | 0.110 |
Actual spot urine protein/creatinine | 0.3±0.5 | 0.28±1.0 | |
Independent t test was used and P |